The impact of rubella immunization on the serological status of women of childbearing age: a retrospective longitudinal study in Melbourne, Australia.
作者信息
Francis Barbara H, Thomas Adrian K, McCarty Catherine A
机构信息
Mercy Hospital for Women, Melbourne, Australia.
出版信息
Am J Public Health. 2003 Aug;93(8):1274-6. doi: 10.2105/ajph.93.8.1274.
Abstract
摘要
相似文献
1
The impact of rubella immunization on the serological status of women of childbearing age: a retrospective longitudinal study in Melbourne, Australia.
Am J Public Health. 2003 Aug;93(8):1274-6. doi: 10.2105/ajph.93.8.1274.
2
Identifying risk factors for rubella susceptibility in a population at risk in the United States.
Am J Public Health. 2003 Feb;93(2):289-91. doi: 10.2105/ajph.93.2.289.
3
Prevention of congenital rubella syndrome--what makes sense in 2006?
Epidemiol Rev. 2006;28:81-7. doi: 10.1093/epirev/mxj007. Epub 2006 Jun 14.
4
Serological statuses of pregnant women in an urban Brazilian population before and after the 2008 rubella immunization campaign.
Vaccine. 2016 Jan 20;34(4):445-450. doi: 10.1016/j.vaccine.2015.12.019. Epub 2015 Dec 18.
5
Rubella vaccination in pregnancy.
CDR (Lond Engl Rev). 1991 Jul 19;1(8):R86-8.
6
Congenital rubella syndrome due to infection after maternal antibody conversion with vaccine.
Jpn J Infect Dis. 2003 Apr;56(2):68-9.
7
Risk of chronic arthropathy among women after rubella vaccination. Vaccine Safety Datalink Team.
JAMA. 1997 Aug 20;278(7):551-6.
8
Reducing the global burden of congenital rubella syndrome: report of the World Health Organization Steering Committee On Research Related To Measles and Rubella Vaccines and Vaccination, June 2004.
J Infect Dis. 2005 Dec 1;192(11):1890-7. doi: 10.1086/497607. Epub 2005 Oct 31.
9
Rubella susceptibility in a population of prenatal care patients.
Bol Asoc Med P R. 1991 Apr;83(4):147-9; discussion 150.
10
Congenital rubella syndrome in child of woman without known risk factors, New Jersey, USA.
Emerg Infect Dis. 2014 Feb;20(2):307-9. doi: 10.3201/eid2002.131233.
引用本文的文献
1
Parity status and the relationship between antenatal rubella serology with obstetric outcome.
Sci Rep. 2022 Jan 24;12(1):1278. doi: 10.1038/s41598-022-05376-8.
2
Impact of the two-dose rubella vaccination regimen on incidence of rubella seronegativity in gravidae aged 25 years and younger.
PLoS One. 2017 Aug 30;12(8):e0183630. doi: 10.1371/journal.pone.0183630. eCollection 2017.
3
Where to Now for Standardization of Anti-Rubella Virus IgG Testing.
J Clin Microbiol. 2016 Jul;54(7):1682-1683. doi: 10.1128/JCM.00800-16. Epub 2016 May 11.
4
Assessing Immunity to Rubella Virus: a Plea for Standardization of IgG (Immuno)assays.
J Clin Microbiol. 2016 Jul;54(7):1720-1725. doi: 10.1128/JCM.00383-16. Epub 2016 May 4.
5
Standardization of Assays That Detect Anti-Rubella Virus IgG Antibodies.
Clin Microbiol Rev. 2016 Jan;29(1):163-74. doi: 10.1128/CMR.00045-15.
6
Investigation into low-level anti-rubella virus IgG results reported by commercial immunoassays.
Clin Vaccine Immunol. 2013 Feb;20(2):255-61. doi: 10.1128/CVI.00603-12. Epub 2012 Dec 19.
7
Rubella immunity among pregnant women in a Canadian provincial screening program.
Can J Infect Dis Med Microbiol. 2009 Fall;20(3):73-7. doi: 10.1155/2009/901372.
8
Evaluation of eight anti-rubella virus immunoglobulin g immunoassays that report results in international units per milliliter.
J Clin Microbiol. 2008 Jun;46(6):1955-60. doi: 10.1128/JCM.00231-08. Epub 2008 Apr 23.
9
Humoral immune response to primary rubella virus infection.
Clin Vaccine Immunol. 2006 Mar;13(3):380-6. doi: 10.1128/CVI.13.3.380-386.2006.
10
Evaluation of three immunoassays used for detection of anti-rubella virus immunoglobulin M antibodies.
Clin Diagn Lab Immunol. 2005 Sep;12(9):1104-8. doi: 10.1128/CDLI.12.9.1104-1108.2005.
本文引用的文献
1
Congenital rubella syndrome: a risk in immigrant populations.
Lancet. 2002 Feb 23;359(9307):674-5. doi: 10.1016/S0140-6736(02)07805-4.
2
The changing epidemiology of rubella in the 1990s: on the verge of elimination and new challenges for control and prevention.
JAMA. 2002;287(4):464-72. doi: 10.1001/jama.287.4.464.
3
Measles, rubella, and congenital rubella syndrome--United States and Mexico, 1997-1999.
MMWR Morb Mortal Wkly Rep. 2000 Nov 24;49(46):1048-50, 1059.
4
Mumps and rubella eliminated from Finland.
JAMA. 2000;284(20):2643-7. doi: 10.1001/jama.284.20.2643.
5
The epidemiology of rubella and congenital rubella in Australia, 1992 to 1997.
Commun Dis Intell. 1999 Aug 5;23(8):209-14. doi: 10.33321/cdi.1999.23.30.
6
The impact of rubella immunisation on the incidence of rubella, congenital rubella syndrome and rubella-related terminations of pregnancy in South Australia.
Br J Obstet Gynaecol. 1998 Sep;105(9):998-1004. doi: 10.1111/j.1471-0528.1998.tb10264.x.
7
Moving the second dose of measles-mumps-rubella vaccine to school entry: implications for control of rubella.
Commun Dis Intell. 1998 Aug 6;22(8):157-8. doi: 10.33321/cdi.1998.22.37.
8
Rubella--could do better.
Lancet. 1998 Mar 21;351(9106):849-50. doi: 10.1016/s0140-6736(05)70283-x.
9
Rubella surveillance to June 1994: third joint report from the PHLS and the National Congenital Rubella Surveillance Programme.
Commun Dis Rep CDR Rev. 1994 Nov 11;4(12):R146-52.
10
Congenital rubella in the Asian community in Britain.
BMJ. 1990 Dec 15;301(6765):1391. doi: 10.1136/bmj.301.6765.1391.
Zotero 插件